Related Experiment Video
Updated: Aug 30, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Standardizing Screening for Preeclampsia Risk Factors to Improve Prescribing of Low-Dose Aspirin
Insights
Implementing an electronic health record (EHR) preeclampsia risk screen improved aspirin prescribing for high-risk pregnancies. This quality improvement initiative standardized care and enhanced patient outcomes in obstetric and family practice settings.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Health Services Research
Background:
- Preeclampsia is a significant cause of maternal and infant complications.
- Low-dose aspirin is recommended for preeclampsia prevention in high-risk individuals.
- Standardized screening and treatment protocols are crucial for effective management.
Purpose of the Study:
- To implement and evaluate an EHR-based preeclampsia risk screening tool.
- To improve the rate of low-dose aspirin prescription for high-risk pregnancies.
- To ensure adherence to clinical guidelines for preeclampsia prevention.
Main Methods:
- A quality improvement project was conducted across 13 OB/GYN and family practice offices.
- An EHR-integrated preeclampsia risk screen was implemented for standardized patient assessment.
- Provider screening and aspirin prescribing rates were monitored using EHR analytics.
Main Results:
- Initial screening rates reached 74.2% in the first 3 months, with 41% testing positive and 81.3% receiving aspirin.
- After 9 months, screening rates improved to 95.6%, with 39.6% positive screens and 97.1% appropriate aspirin prescription.
- The EHR tool demonstrated significant improvements in screening and prescribing adherence.
Conclusions:
- EHR implementation of a preeclampsia risk screen effectively standardized care.
- The project successfully increased the appropriate use of low-dose aspirin for preeclampsia prevention.
- This quality improvement initiative positively impacted maternal healthcare delivery and patient safety.
Abstract:
Preeclampsia is a serious health condition and leading cause of perinatal and neonatal morbidity and mortality. Research supports the use of low-dose aspirin therapy to prevent preeclampsia in high-risk pregnant people. This quality improvement project outlines the implementation of a preeclampsia risk screen in the electronic health record to ensure standardized screening for, and provision of, low-dose aspirin therapy consistent with professional guidelines. Two thousand three hundred seventy-one patients were seen between March and November 2020 at 13 OB/GYN and family practice offices at a large health system in our state. Provider screening and prescribing rates were evaluated at the first prenatal visit, and at 3-month intervals using an analytics dashboard built in the EHR. In the first 3 months after rollout visits at all offices in our system (March to May 2020), the average screening rate during first prenatal visits at all offices was 74.2% (n = 561), 41% (n = 230) had a positive screen, and 81.3% (n = 187) of those who screened high risk were prescribed aspirin as recommended. At 9 months after rollout, the screening rate during first prenatal visits at all offices improved to 95.6% (n = 782), 39.6% (n = 310) of those screened, screened positive, and 97.1% (n = 301) were prescribed low-dose aspirin therapy appropriately.
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Atherosclerosis III: Management
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Hypertension V: Nursing Management
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:

